Tumor immunology and cancer immunotherapy: summary of the 2013 SITC primer

por Raval, Raju R, Sharabi, Andrew B, Walker, Amanda J, Drake, Charles G, Sharma, Padmanee
Publicado em 2014

Stereotactic Radiotherapy combined with Immunotherapy: Augmenting Radiation’s Role in Local and Systemic Treatment

por Sharabi, Andrew B., Tran, Phuoc T., Lim, Michael, Drake, Charles G., DeWeese, Theodore L.
Publicado no Oncology (Williston Park) (2015)

Enhanced Generation of Myeloid Lineages in Hematopoietic Differentiation from Embryonic Stem Cells by Silencing Transcriptional Repressor Twist-2

por Sharabi, Andrew B., Lee, Sung-Hyung, Goodell, Margaret A., Huang, Xue F., Chen, Si-Yi
Publicado em 2009

Scirrhous carcinoma: A previously undescribed tumor of the oral cavity

por DeVries, Jacquelyn, Finegersh, Andrey, Gold, Kathryn A., Sharabi, Andrew B., Hu, Jingjing, Orosco, Ryan K.
Publicado no Clin Case Rep (2021)

Association of HIV Status With Outcomes of Anal Squamous Cell Carcinoma in the Era of Highly Active Antiretroviral Therapy

por Bryant, Alex K., Huynh-Le, Minh-Phuong, Simpson, Daniel R., Gupta, Samir, Sharabi, Andrew B., Murphy, James D.
Publicado no JAMA Oncol (2017)

Twist-2 Controls Myeloid Lineage Development and Function

por Sharabi, Andrew B, Aldrich, Melissa, Sosic, Drazen, Olson, Eric N, Friedman, Alan D, Lee, Sung-Hyung, Chen, Si-Yi
Publicado em 2008

Stereotactic Radiation Therapy Augments Antigen-Specific PD-1-Mediated Anti-Tumor Immune Responses via Cross-Presentation of Tumor Antigen

por Sharabi, Andrew B., Nirschl, Christopher J., Kochel, Christina M., Nirschl, Thomas R., Francisca, Brian J., Velarde, Esteban, Deweese, Theodore L., Drake, Charles G.
Publicado no Cancer Immunol Res (2014)

A Threshold Model for T-Cell Activation in the Era of Checkpoint Blockade Immunotherapy

por Guram, Kripa, Kim, Sangwoo S., Wu, Victoria, Sanders, P. Dominick, Patel, Sandip, Schoenberger, Stephen P., Cohen, Ezra E. W., Chen, Si-Yi, Sharabi, Andrew B.
Publicado no Front Immunol (2019)

Radiation Recall Pneumonitis After Treatment With Checkpoint Blockade Immunotherapy: A Case Series and Review of Literature

por Riviere, Paul, Sumner, Whitney, Cornell, Mariel, Sandhu, Ajay, Murphy, James D., Hattangadi-Gluth, Jona, Bruggeman, Andrew, Kim, Sangwoo S., Randall, J. Michael, Sharabi, Andrew B.
Publicado no Front Oncol (2021)

Radiation Therapy Combined With Checkpoint Blockade Immunotherapy for Metastatic Undifferentiated Pleomorphic Sarcoma of the Maxillary Sinus With a Complete Response

por Guram, Kripa, Nunez, Maria, Einck, John, Mell, Loren K., Cohen, Ezra, Sanders, P. Dominick, Miyauchi, Sayuri, Weihe, Elizabeth, Kurzrock, Razelle, Boles, Sarah, Sharabi, Andrew B.
Publicado no Front Oncol (2018)

Immune modulation of head and neck squamous cell carcinoma and the tumor microenvironment by conventional therapeutics

por Miyauchi, Sayuri, Kim, Sangwoo S., Pang, John, Gold, Kathryn A., Gutkind, J. Silvio, Califano, Joseph A., Mell, Loren K., Cohen, Ezra E. W., Sharabi, Andrew B.
Publicado no Clin Cancer Res (2019)

HPV16 E5 Mediates Resistance to PD-L1 Blockade and can be targeted with Rimantadine in Head and Neck Cancer

por Miyauchi, Sayuri, Sanders, P. Dominick, Guram, Kripa, Kim, Sangwoo S., Paolini, Francesca, Venuti, Aldo, Cohen, Ezra E. W., Gutkind, J. Silvio, Califano, Joseph A., Sharabi, Andrew B.
Publicado no Cancer Res (2019)

B-cells improve overall survival in HPV-associated squamous cell carcinomas and are activated by radiation and PD-1 blockade.

por Kim, Sangwoo Shawn, Shen, Sarek, Miyauchi, Sayuri, Sanders, Philip Dominick, Franiak-Pietryga, Ida, Mell, Loren K., Gutkind, J. Silvio, Cohen, Ezra E.W., Califano, Joseph, Sharabi, Andrew B.
Publicado no Clin Cancer Res (2020)

High Tumor Mutational Burden Correlates with Longer Survival in Immunotherapy-Naïve Patients with Diverse Cancers

por Riviere, Paul, Goodman, Aaron M, Okamura, Ryosuke, Barkauskas, Donald A., Whitchurch, Theresa J, Lee, Suzanna, Khalid, Noor, Collier, Rachel, Mareboina, Manvita, Frampton, Garrett M., Fabrizio, David, Sharabi, Andrew B., Kato, Shumei, Kurzrock, Razelle
Publicado no Mol Cancer Ther (2020)

TNFα and Radioresistant Stromal Cells Are Essential for Therapeutic Efficacy of Cyclic Dinucleotide STING Agonists in Nonimmunogenic Tumors

por Francica, Brian J., Ghasemzadeh, Ali, Desbien, Anthony L., Theodros, Debebe, Sivick, Kelsey E., Reiner, Gabrielle L., Glickman, Laura Hix, Marciscano, Ariel E., Sharabi, Andrew B., Leong, Meredith L., McWhirter, Sarah M., Dubensky, Thomas W., Pardoll, Drew M., Drake, Charles G.
Publicado no Cancer Immunol Res (2018)

Macrophage Syk-PI3Kγ inhibits anti-tumor immunity: SRX3207, a novel dual Syk-PI3K inhibitory chemotype relieves tumor immunosuppression

por Joshi, Shweta, Liu, Kevin X., Zulcic, Muamera, Singh, Alok R., Skola, Dylan, Glass, Christopher K., Sanders, P. Dominick, Sharabi, Andrew B., Pham, Timothy V., Tamayo, Pablo, Shiang, Daniel, Dinh, Huy Q., Hedrick, Catherine C., Morales, Guillermo A., Garlich, Joseph R., Durden, Donald L.
Publicado no Mol Cancer Ther (2020)

Re-irradiation with stereotactic body radiation therapy as a novel treatment option for isolated local recurrence of pancreatic cancer after multimodality therapy: experience from...

por Wild, Aaron T., Hiniker, Susan M., Chang, Daniel T., Tran, Phuoc T., Khashab, Mouen A., Limaye, Maneesha R., Laheru, Daniel A., Le, Dung T., Kumar, Rachit, Pai, Jonathan S., Hargens, Blaire, Sharabi, Andrew B., Shin, Eun Ji, Zheng, Lei, Pawlik, Timothy M., Wolfgang, Christopher L., Koong, Albert C., Herman, Joseph M.
Publicado em 2013

Syngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti-CTLA-4

por Wang, Zhiyong, Wu, Victoria H., Allevato, Michael M., Gilardi, Mara, He, Yudou, Luis Callejas-Valera, Juan, Vitale-Cross, Lynn, Martin, Daniel, Amornphimoltham, Panomwat, Mcdermott, James, Yung, Bryan S., Goto, Yusuke, Molinolo, Alfredo A., Sharabi, Andrew B., Cohen, Ezra E. W., Chen, Qianming, Lyons, J. Guy, Alexandrov, Ludmil B., Gutkind, J. Silvio
Publicado no Nat Commun (2019)

Elective nodal irradiation attenuates the combinatorial efficacy of stereotactic radiation therapy and immunotherapy

por Marciscano, Ariel E., Ghasemzadeh, Ali, Nirschl, Thomas R., Theodros, Debebe, Kochel, Christina M., Francica, Brian J., Muroyama, Yuki, Anders, Robert A., Sharabi, Andrew B., Velarde, Esteban, Mao, Wendy, Chaudhary, Kunal R., Chaimowitz, Matthew G., Wong, John, Selby, Mark J., Thudium, Kent B., Korman, Alan J., Ulmert, David, Thorek, Daniel L.J., DeWeese, Theodore L., Drake, Charles G.
Publicado no Clin Cancer Res (2018)